Anthony Maddaluna Insider Profile
4 Followers
Anthony Maddaluna, Director at Indaptus Therapeutics, holds 53.57K shares in Indaptus Therapeutics (Ticker: INDP), holds 2.85K shares in Albany Molecular Research (Ticker: AMRI), holds 176.79K shares in Pfizer (Ticker: PFE). Most recently, Anthony Maddaluna Bought ― shares of Indaptus Therapeutics on Aug 29, 2019 for an estimated value of $11.75K.
Anthony Maddaluna's Trading History
You May Also Like
Anthony Maddaluna insider profile FAQ
What is the percentage of profitable transactions made by Anthony Maddaluna?
The percentage of profitable transactions made by Anthony Maddaluna is 25%.
What is the average return per transaction made by Anthony Maddaluna?
The average return per transaction made by Anthony Maddaluna is -9.80%.
What stocks does Anthony Maddaluna hold?
Anthony Maddaluna holds: INDP, AMRI, PFE stocks.
What was Anthony Maddaluna’s latest transaction?
Anthony Maddaluna’s latest transaction was an Informative Buy of $11.75K.
What was Anthony Maddaluna's most profitable transaction?
Anthony Maddaluna’s most profitable transaction was an Informative Sell of PFE stock on February 13, 2015. The return on the trade was 12.30%.
What is Anthony Maddaluna's role in Indaptus Therapeutics?
Anthony Maddaluna's role in Indaptus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
